VIRODEX Trademark

Trademark Overview


On Friday, June 9, 2023, a trademark application was filed for VIRODEX with the United States Patent and Trademark Office. The USPTO has given the VIRODEX trademark a serial number of 79382275. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, September 19, 2024. This trademark is owned by Croda International Plc. The VIRODEX trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Adjuvants for pharmaceutical, medical or veterinary use

Chemicals for use in industry, in particular additives for the pharmaceutical industry; chemicals for use in the manufacture of pharmaceutical, medical or veterinary products; adjuvants and excipients for use in the manufacture of pharmaceutical and veterinary preparations for scientific or research use; adjuvants and excipients for use in the manufacture of pharmaceutical, medical or veterinary products; carrier excipients for use in the manufacture of pharmaceutical preparations
virodex

General Information


Serial Number79382275
Word MarkVIRODEX
Filing DateFriday, June 9, 2023
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAdjuvants for pharmaceutical, medical or veterinary use
Goods and ServicesChemicals for use in industry, in particular additives for the pharmaceutical industry; chemicals for use in the manufacture of pharmaceutical, medical or veterinary products; adjuvants and excipients for use in the manufacture of pharmaceutical and veterinary preparations for scientific or research use; adjuvants and excipients for use in the manufacture of pharmaceutical, medical or veterinary products; carrier excipients for use in the manufacture of pharmaceutical preparations

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, November 3, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCroda International Plc
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressGB

Trademark Events


Event DateEvent Description
Thursday, November 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, February 29, 2024ASSIGNED TO EXAMINER
Friday, March 1, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 26, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 26, 2024REFUSAL PROCESSED BY MPU
Monday, September 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 16, 2024REFUSAL PROCESSED BY IB
Friday, November 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 7, 2023APPLICATION FILING RECEIPT MAILED
Thursday, February 29, 2024NON-FINAL ACTION WRITTEN